HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Campion Selected Research

abarelix (Plenaxis)

11/2001A phase 3, multicenter, open-label, randomized study of abarelix versus leuprolide acetate in men with prostate cancer.
5/2001The gonadotropin-releasing hormone antagonist abarelix depot versus luteinizing hormone releasing hormone agonists leuprolide or goserelin: initial results of endocrinological and biochemical efficacies in patients with prostate cancer.
1/2000Abarelix Depot, a GnRH antagonist, v LHRH superagonists in prostate cancer: differential effects on follicle-stimulating hormone. Abarelix Depot study group.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Campion Research Topics

Disease

3Prostatic Neoplasms (Prostate Cancer)
11/2001 - 01/2000
2Infections
12/2009 - 01/2008
1Staphylococcal Infections
12/2009
1Infectious Arthritis (Septic Arthritis)
01/2008
1Osteomyelitis
01/2008

Drug/Important Bio-Agent (IBA)

3abarelix (Plenaxis)FDA Link
11/2001 - 01/2000
2DaptomycinFDA Link
12/2009 - 01/2008
2Leuprolide (Lupron)FDA LinkGeneric
11/2001 - 05/2001
2Androgen Antagonists (Antiandrogens)IBA
05/2001 - 01/2000
2Gonadotropin-Releasing Hormone (GnRH)FDA Link
05/2001 - 01/2000
1Testosterone (Sustanon)FDA Link
11/2001
1Hormones (Hormone)IBA
11/2001
1Goserelin (Zoladex)FDA Link
05/2001
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2000
1Follicle Stimulating Hormone (Follitropin)FDA Link
01/2000

Therapy/Procedure

3Therapeutics
12/2009 - 05/2001